https://www.home.saxo/fr-be/markets/stocks/bcrx-xnas
Biocryst Pharmaceuticals Inc. action | Saxo Bank
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes...
biocryst pharmaceuticals incactionsaxobank
https://www.insidermonkey.com/blog/biocryst-pharmaceuticals-inc-nasdaqbcrx-q1-2024-earnings-call-transcript-1298302/
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript - Insider Monkey
BioCryst Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.31 EPS, expectations were $-0.23.
biocryst pharmaceuticals incearnings call transcriptq1 2024
https://www.fool.com/earnings/call-transcripts/2019/08/06/biocryst-pharmaceuticals-inc-bcrx-q2-2019-earnings.aspx
Biocryst Pharmaceuticals Inc (BCRX) Q2 2019 Earnings Call Transcript | The Motley Fool
Aug 6, 2019 - BCRX earnings call for the period ending June 30, 2019.
biocryst pharmaceuticals incearnings call transcriptq2 2019
https://www.finanznachrichten.de/nachrichten-2025-07/65843226-biocryst-pharmaceuticals-inc-biocryst-appoints-babar-ghias-chief-financial-officer-and-head-of-corporate-development-399.htm
BioCryst Pharmaceuticals, Inc.: BioCryst Appoints Babar Ghias Chief Financial Officer and Head of...
RESEARCH TRIANGLE PARK, N.C., July 07, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the appointment of Babar Ghias as...
biocryst pharmaceuticals incchief financial officer
https://www.fxempire.com/stocks/bcrx/earnings
BioCryst Pharmaceuticals Inc (BCRX) Earnings Reports & Dates | FXEmpire
Dive into BioCryst Pharmaceuticals Inc financial stats - earnings and revenue, analyze past reports, compare to industry peers' performance, and stay informed...
biocryst pharmaceuticals incearnings reportsbcrxdates